Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine
2
Endocrinology Department, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing 314001,China
|
Тип публикации: Journal Article
Дата публикации: 2020-09-11
scimago Q3
wos Q3
БС3
SJR: 0.535
CiteScore: 4.4
Impact factor: 2.0
ISSN: 18715303, 22123873
PubMed ID:
32914727
Immunology and Allergy
Endocrinology, Diabetes and Metabolism
Краткое описание
Berberine (BBR) is a botanic alkaloid extracted from Coptis chinensis (Huanglian), which has various properties, compassing anti-hyperglycemia, anti-obesity, anti-inflammation, and improves insulin resistance, etc. Several researches have confirmed that BBR has effective actions in treating glycolipid metabolic abnormalities. BBR is also beneficial in regulating intestinal flora. Metabolic diseases are strongly associated with metabolic disorders, which are growing in the population and dramatically impacting human health, which also have been considered as a leading cause of diseases and death globally. This review is to evaluate the metabolic properties of BBR, and its potential application to the treatment of metabolic diseases by its effective actions on metabolic disorders.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
1
2
|
|
|
Journal of Ethnopharmacology
2 публикации, 8.7%
|
|
|
Evidence-based Complementary and Alternative Medicine
2 публикации, 8.7%
|
|
|
Journal of Diabetes Research
2 публикации, 8.7%
|
|
|
Endocrine, Metabolic and Immune Disorders - Drug Targets
1 публикация, 4.35%
|
|
|
Molecules
1 публикация, 4.35%
|
|
|
Pharmaceutics
1 публикация, 4.35%
|
|
|
Frontiers in Medicine
1 публикация, 4.35%
|
|
|
Frontiers in Cellular and Infection Microbiology
1 публикация, 4.35%
|
|
|
Frontiers in Endocrinology
1 публикация, 4.35%
|
|
|
Phytotherapy Research
1 публикация, 4.35%
|
|
|
BioMed Research International
1 публикация, 4.35%
|
|
|
Journal of Gastrointestinal Oncology
1 публикация, 4.35%
|
|
|
Crystal Research and Technology
1 публикация, 4.35%
|
|
|
Journal of Advanced Research
1 публикация, 4.35%
|
|
|
Heliyon
1 публикация, 4.35%
|
|
|
Russian Chemical Reviews
1 публикация, 4.35%
|
|
|
Phytomedicine
1 публикация, 4.35%
|
|
|
Chemical Engineering Journal
1 публикация, 4.35%
|
|
|
European Journal of Medicinal Chemistry
1 публикация, 4.35%
|
|
|
Biointerphases
1 публикация, 4.35%
|
|
|
1
2
|
Издатели
|
1
2
3
4
5
6
7
|
|
|
Elsevier
7 публикаций, 30.43%
|
|
|
Hindawi Limited
4 публикации, 17.39%
|
|
|
Frontiers Media S.A.
3 публикации, 13.04%
|
|
|
Wiley
3 публикации, 13.04%
|
|
|
MDPI
2 публикации, 8.7%
|
|
|
Bentham Science Publishers Ltd.
1 публикация, 4.35%
|
|
|
AME Publishing Company
1 публикация, 4.35%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 4.35%
|
|
|
American Vacuum Society
1 публикация, 4.35%
|
|
|
1
2
3
4
5
6
7
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
23
Всего цитирований:
23
Цитирований c 2024:
10
(43.48%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Wang S. et al. Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine // Endocrine, Metabolic and Immune Disorders - Drug Targets. 2020. Vol. 21. No. 6. pp. 971-979.
ГОСТ со всеми авторами (до 50)
Скопировать
Wang S., ZHANG X., Cai B., Qiu C. Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine // Endocrine, Metabolic and Immune Disorders - Drug Targets. 2020. Vol. 21. No. 6. pp. 971-979.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.2174/1871530320666200910105612
UR - https://doi.org/10.2174/1871530320666200910105612
TI - Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine
T2 - Endocrine, Metabolic and Immune Disorders - Drug Targets
AU - Wang, Sheng-Ju
AU - ZHANG, Xu
AU - Cai, Baochao
AU - Qiu, Chen
PY - 2020
DA - 2020/09/11
PB - Bentham Science Publishers Ltd.
SP - 971-979
IS - 6
VL - 21
PMID - 32914727
SN - 1871-5303
SN - 2212-3873
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2020_Wang,
author = {Sheng-Ju Wang and Xu ZHANG and Baochao Cai and Chen Qiu},
title = {Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine},
journal = {Endocrine, Metabolic and Immune Disorders - Drug Targets},
year = {2020},
volume = {21},
publisher = {Bentham Science Publishers Ltd.},
month = {sep},
url = {https://doi.org/10.2174/1871530320666200910105612},
number = {6},
pages = {971--979},
doi = {10.2174/1871530320666200910105612}
}
Цитировать
MLA
Скопировать
Wang, Sheng-Ju, et al. “Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine.” Endocrine, Metabolic and Immune Disorders - Drug Targets, vol. 21, no. 6, Sep. 2020, pp. 971-979. https://doi.org/10.2174/1871530320666200910105612.